Atherosclerosis and Hyperlipidemia

ACC.24: Olezarsen for Hypertriglyceridemia and ASCVD

Brian Bergmark,

Watch time: 3m 40s
ACC.24: The LIBerate-CVD Trial

Evan A Stein,

Watch time: 7m 18s

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 1h 35m 42s (16 videos)
ESC 23: LIBerate-HeFH Study

Frederick Raal,

Watch time: 4m 16s
ESC 23: OCEAN(a)-DOSE Trial Update

Michelle O'Donoghue,

Watch time: 3m 22s

Joost Daemen, Allen Jeremias, Ziad A Ali, et al

Watch time: 55m 46s (1 video)

Marinela Beznă , Gabriela Mitoaica , Lorena Ungureanu , et al

Read time: 1 Min
Dietary Sodium Intake and Atherosclerosis

Jonas Wuopio,

Watch time: 3m 1s
ACC 23: Lipid Management & the CLEAR Trial with Dr Michos

Erin D Michos,

Watch time: 5m 34s
View from the Thoraxcenter: ACC.23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 33m 36s
ACC 23: MK-0616: Oral PCSK9 inhibitor In Hypercholesterolemia Patients

Christie Ballantyne,

Watch time: 3m 44s
ACC 23: Effect of Evolocumab on Coronary Plaque Morphology: The YELLOW III Study

Annapoorna Kini ,

Watch time: 8m 1s

Hans-Willi Breuer ,

Ewa Dembowski , Michael H Davidson ,

Sumanth Khadke , Jovana Vidovic , Vinod Patel ,

Alberto Lorenzatti , Peter P Toth ,

Kausik Ray, , , et al

Watch time: 1h 35m (4 videos)

Kerry Layne , Albert Ferro ,

Maciej Banach, Yassir Javaid, Lale Tokgözoğlu, et al

Watch time: 1h 27m 1s

Yassir Javaid, , , et al

Watch time: 18m 47s (4 videos)

Cameron T Lambert , Pratik Sandesara , Ijeoma Isiadinso , et al

Iana Simova ,

Reynaria N Pitts , Robert Eckel ,

Kazeen Abdullah , Anand Rohatgi ,

Read time: 18m

Media

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 1h 35m 42s (16 videos)

Joost Daemen, Allen Jeremias, Ziad A Ali, et al

Watch time: 55m 46s (1 video)
ACC 23: Effect of Evolocumab on Coronary Plaque Morphology: The YELLOW III Study

Annapoorna Kini ,

Watch time: 8m 1s
ACC.23 Late-Breaker Discussion: The CLEAR-Outcomes Trial

Harriette Van Spall, Steven E Nissen,

Watch time: 16m 12s
View from the Thoraxcenter: What's Hot at ACC.23?

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 22m 4s
Radcliffe & CardioNerds @AHA22: Reduction of Lp(a) With Small Interfering RNA

Gurleen Kaur, Michelle O'Donoghue,

Watch time: 14m 28s
Radcliffe & CardioNerds @AHA22: Reduction of Triglycerides With Pemafibrate

Aruna D Pradhan, Gurleen Kaur,

Watch time: 14m 20s

Yassir Javaid, , , et al

Watch time: 18m 47s (4 videos)

Maciej Banach, Yassir Javaid, Lale Tokgözoğlu, et al

Watch time: 1h 27m 1s

Media

ACC.24: The LIBerate-CVD Trial

Evan A Stein,

Watch time: 7m 18s
ACC.24: Olezarsen for Hypertriglyceridemia and ASCVD

Brian Bergmark,

Watch time: 3m 40s

Joost Daemen, Allen Jeremias, Ziad A Ali, et al

Watch time: 55m 46s (1 video)

Yassir Javaid, , , et al

Watch time: 18m 47s (4 videos)
ACC 23: MK-0616: Oral PCSK9 inhibitor In Hypercholesterolemia Patients

Christie Ballantyne,

Watch time: 3m 44s
ACC 23: Effect of Evolocumab on Coronary Plaque Morphology: The YELLOW III Study

Annapoorna Kini ,

Watch time: 8m 1s
ACC.23 Late-Breaker Discussion: The CLEAR-Outcomes Trial

Harriette Van Spall, Steven E Nissen,

Watch time: 16m 12s
ESC 23: OCEAN(a)-DOSE Trial Update

Michelle O'Donoghue,

Watch time: 3m 22s
ESC 23: LIBerate-HeFH Study

Frederick Raal,

Watch time: 4m 16s

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 1h 35m 42s (16 videos)

Maciej Banach, Yassir Javaid, Lale Tokgözoğlu, et al

Watch time: 1h 27m 1s
Radcliffe & CardioNerds @AHA22: Reduction of Triglycerides With Pemafibrate

Aruna D Pradhan, Gurleen Kaur,

Watch time: 14m 20s

Articles

Sphingomyelin and Cardiovascular Implications

Petros Kikas

,

George Chalikias

,

Dimitrios Tziakas

,

Citation:

European Cardiology Review 2018;13(1):42–5.

DOI:

https://doi.org/10.15420/ecr.2017:20:3
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1237
  • Downloads: Downloads 7
  • Citations: 27

Inflammation Revisited: Atherosclerosis in The Post-CANTOS Era

Wolfgang Koenig

,

Citation:

European Cardiology Review 2017;12(2):89–91

DOI:

https://doi.org/10.15420/ecr.2017:18:1
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 668
  • Downloads: Downloads 5
  • Citations: 18

Cardiovascular Risk Management Targeting Inflammation in Addition to Lipid-lowering Therapy

Koji Hasegawa

,

Citation:

European Cardiology Review 2017;12(2):88

DOI:

https://doi.org/10.15420/ecr.2017:25:1
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 517
  • Downloads: Downloads 6

Effects of Pharmacotherapy for Smoking Cessation on LOX Index, a Cardiovascular Risk Marker

Maki Komiyama

,

Hiromichi Wada

,

Hajime Yamakage

,

Noriko Asahara

,

Sayaka Shimada

,

Masaharu Akao

,

Tatsuya Morimoto

,

Yuko Takahashi

,

Tatsuya Sawamura

,

Koji Hasegawa

,

Citation:

European Cardiology Review 2017;12(2):96.

DOI:

https://doi.org/10.15420/ecr.2017:23:5
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 314
  • Downloads: Downloads 2